|
Volumn 72, Issue 4, 2010, Pages 566-568
|
Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS)
a b c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
METFORMIN;
PLACEBO;
ADULT;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
HYPERANDROGENISM;
INSULIN RESISTANCE;
LETTER;
OVARY POLYCYSTIC DISEASE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THERAPY EFFECT;
TREATMENT RESPONSE;
ADULT;
C-REACTIVE PROTEIN;
DRUG SYNERGISM;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INSULIN RESISTANCE;
METFORMIN;
POLYCYSTIC OVARY SYNDROME;
PYRROLES;
TESTOSTERONE;
|
EID: 77749294997
PISSN: 03000664
EISSN: 13652265
Source Type: Journal
DOI: 10.1111/j.1365-2265.2009.03678.x Document Type: Letter |
Times cited : (24)
|
References (6)
|